Form 4: uniQure N.V. Director Sells Shares to Cover Tax Obligations

Director Madhavan Balachandran sold 2,231 ordinary shares of uniQure N.V. to cover estimated withholding taxes upon vesting of restricted share units.

Summary

• On June 13, 2024, Madhavan Balachandran, a director of uniQure N.V., sold 2,231 ordinary shares of the company.
• The shares were sold at a weighted average price of $5.12, with individual transactions ranging from $5.12 to $5.15.
• The sale was executed to cover estimated withholding taxes associated with the vesting of restricted share units.
• Following the transaction, Balachandran directly owns 23,759 ordinary shares of uniQure N.V.

Sentiment

Score: 6

Explanation: The document reflects a neutral sentiment as it reports a routine transaction (sale of shares for tax obligations). It doesn't indicate any positive or negative outlook for the company.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and directors. This transaction is a routine financial activity and doesn't necessarily indicate a change in the director's confidence in the company.

Comparison to Industry Standards

• Similar transactions are regularly observed among executives and directors in comparable biotechnology companies such as BioMarin Pharmaceutical Inc., Sarepta Therapeutics, and Vertex Pharmaceuticals.
• These companies often grant restricted stock units as part of their compensation packages, leading to periodic sales to cover tax liabilities.
• The scale of this transaction (2,231 shares) is relatively small compared to the overall trading volume of QURE and similar companies, suggesting it is unlikely to have a significant impact on the stock price.

Stakeholder Impact

• The sale of shares is unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors, as it is a routine transaction.

Key Dates